Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI)

Information

  • Research Project
  • 10011049
  • ApplicationId
    10011049
  • Core Project Number
    R44GM137743
  • Full Project Number
    1R44GM137743-01
  • Serial Number
    137743
  • FOA Number
    PA-19-272
  • Sub Project Id
  • Project Start Date
    5/1/2020 - 4 years ago
  • Project End Date
    10/31/2020 - 3 years ago
  • Program Officer Name
    SMITH, WARD
  • Budget Start Date
    5/1/2020 - 4 years ago
  • Budget End Date
    10/31/2020 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    4/7/2020 - 4 years ago
Organizations

Development of a Quantitative Iron Characterization System for Alzheimer's Disease Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI)

Title: Development of a Quantitative Iron Characterization System for Alzheimer's Using Computed Laminography X-ray Fluorescence Imaging (CL-XRFI) Project Summary/Abstract The discovery of ferroptosis has invigorated new therapeutics to prevent and/or alter pathological iron distribution in the brain correlated with Alzheimer?s disease (AD) and other neurodegenerative diseases. To efficiently evaluate new drug designs, techniques capable of directly imaging and quantifying the trace levels of iron in brain samples are required. Current approaches include LA-ICPMS and synchrotron microXRF, which each have their own drawbacks in terms of speed, quantification reliability, and accessibility. We propose to develop a scheme called computed laminography x-ray fluorescence imaging (CL-XRFI). In this novel system design, an x-ray beam is focused into a pencil-like beam incident upon a sample at a very low angle (3 degrees). A detector is placed parallel to the sample surface to maximize solid angle. Acquisition is similar in concept to absorption-based laminography, in which acquisition at multiple angles are taken for reconstruction of the signal origin. The system design is uniquely enabled by the company?s patented high brightness x-ray source and its proprietary x-ray optic technology that provides the large working distances necessary for the technique to work. The proposed Phase I 6-month project is a proof-of-principle demonstration of the sensitivity and throughput of a breadboard low angle incidence fluorescence system. The proposed Phase II 24-month project is to develop a complete prototype of the CL-XRFI.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    247818
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:247818\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SIGRAY, INC.
  • Organization Department
  • Organization DUNS
    079183051
  • Organization City
    CONCORD
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    945205345
  • Organization District
    UNITED STATES